AR033946A1 - Un sistema terapeutico transdermal que comprende microreservorios y un procedimiento para la manufactura de sistemas de microreservorios basados en polisiloxanos y solventes ambifilos. - Google Patents

Un sistema terapeutico transdermal que comprende microreservorios y un procedimiento para la manufactura de sistemas de microreservorios basados en polisiloxanos y solventes ambifilos.

Info

Publication number
AR033946A1
AR033946A1 ARP000103345A ARP000103345A AR033946A1 AR 033946 A1 AR033946 A1 AR 033946A1 AR P000103345 A ARP000103345 A AR P000103345A AR P000103345 A ARP000103345 A AR P000103345A AR 033946 A1 AR033946 A1 AR 033946A1
Authority
AR
Argentina
Prior art keywords
active substance
solvent
weight
manufacture
ambipyl
Prior art date
Application number
ARP000103345A
Other languages
English (en)
Spanish (es)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR033946A1 publication Critical patent/AR033946A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP000103345A 1999-07-02 2000-06-30 Un sistema terapeutico transdermal que comprende microreservorios y un procedimiento para la manufactura de sistemas de microreservorios basados en polisiloxanos y solventes ambifilos. AR033946A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19930340 1999-07-02
DE19958554A DE19958554C2 (de) 1999-07-02 1999-12-04 Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung

Publications (1)

Publication Number Publication Date
AR033946A1 true AR033946A1 (es) 2004-01-21

Family

ID=7913294

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103345A AR033946A1 (es) 1999-07-02 2000-06-30 Un sistema terapeutico transdermal que comprende microreservorios y un procedimiento para la manufactura de sistemas de microreservorios basados en polisiloxanos y solventes ambifilos.

Country Status (5)

Country Link
KR (1) KR100685553B1 (ko)
AR (1) AR033946A1 (ko)
DE (3) DE19958554C2 (ko)
IL (1) IL147247A (ko)
ZA (1) ZA200110455B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
PL219512B1 (pl) * 2003-04-14 2015-05-29 Lohmann Therapie Syst Lts Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego
KR101148315B1 (ko) * 2003-08-07 2012-07-05 에르테에스 로만 테라피-시스테메 아게 피복 박편상에 방벽 효과를 지닌 오르모서를 포함하는 피부 또는 경피성 치료학적 제제
DE10348046A1 (de) * 2003-10-16 2005-05-19 Beiersdorf Ag Verfahren zur Herstellung von Matrizes für transdermale oder topicale Wirkstoffsysteme
CA2544291C (en) * 2003-10-27 2013-01-08 University Of Basel Transdermal drug delivery method and system
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
DE102007041557B4 (de) * 2007-08-29 2011-03-31 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend längliche Hohlkörper
EP2729148A4 (en) 2011-07-06 2015-04-22 Parkinson S Inst COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE
TW201338813A (zh) 2011-12-12 2013-10-01 Lohmann Therapie Syst Lts 經皮遞送系統
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
JP6559121B2 (ja) 2013-06-04 2019-08-14 エルテーエス ローマン テラピー−ジステーメ アーゲー 経皮送達システム
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
CA2977814A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
DE102018118507A1 (de) * 2018-07-31 2020-02-06 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Scopolamin ohne Membran

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2153533C3 (de) * 1971-10-27 1974-12-12 Varta Batterie Ag, 3000 Hannover Elektrische Akkumulatorenzelle
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
DE3685895T2 (de) * 1985-02-25 1992-12-24 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.

Also Published As

Publication number Publication date
IL147247A (en) 2006-12-31
KR100685553B1 (ko) 2007-02-22
KR20020015359A (ko) 2002-02-27
DE19958554C2 (de) 2002-06-13
DE122006000008I1 (de) 2006-06-29
ZA200110455B (en) 2002-10-16
DE50001450D1 (de) 2003-04-17
DE19958554A1 (de) 2001-01-11

Similar Documents

Publication Publication Date Title
AR033946A1 (es) Un sistema terapeutico transdermal que comprende microreservorios y un procedimiento para la manufactura de sistemas de microreservorios basados en polisiloxanos y solventes ambifilos.
ES2194736T3 (es) Sistema de microdepositos sobre la base de polisiloxanos y disolvente ambifilos.
ES2581574T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
CY1105647T1 (el) Γαλακτωματα για συστηματα απελευθερωσης in-situ
ECSP067027A (es) Formulaciones acuosas pobres en espuma para la proteccion de las plantas
ES2406958T3 (es) Sistema terapéutico transdermal con una capa adhesiva, procedimiento para la siliconización de una capa de respaldo del sistema y utilización de la capa de respaldo
ES2288222T3 (es) Parche terapeutico con matriz de polisiloxano que comprende capsaicina.
AR018637A1 (es) Un fertilizante de liberacion controlada y un procedimiento para su preparacion
AR008622A1 (es) Una composicion cosmetica para el tratamiento de la piel
CO5560533A2 (es) Preparacion de una composicion farmaceutica de liberacion sostenida
BR9507313A (pt) Composição liquida de liberação adequada para a formação de um implante de liberação controlada sistema polimérico curativo filmico microporoso biodegradável precursor de implante de liberação controlada para a implantação em um indivíduo polímero termoplástico solvente orgánico composicão de pré-polimero liquido componente de liberação controlada agente ativo uso da composição liquida de liberação e processos para forma um implante microporoso de liberação prolongada e para liberar um agente ativo em um individuo
BRPI0408925A (pt) veìculos de fase simples não-aquosos e formulações utilizando tais veìculos
NO20050472L (no) Forbedret transdermalt leveringssystem for administrering av rotigotin
BR0201002A (pt) Dispositivo de tratamento compreendendo uma cobertura que define uma cavidade dentro da qual uma porção do corpo pode ser engatada
ES2137993T3 (es) La utilizacion de glicerina para moderar el aporte transdermico de medicamentos.
CY1105878T1 (el) Βελτιωμενο συστημα διαδepμικης χορηγησης
BR9904742A (pt) Patch, conjunto constituìdo por um patch e por um recipiente, e processo
RU2002102869A (ru) Микрорезервуарная система на основе полисилоксанов и амбифильных растворителей
ES2170943T3 (es) Procedimiento para la fabricacion de un material termooptico variable y uso del mismo.
CR7078A (es) Preparado de parche para uso topico que contiene un agente inductor de hipersensibilidad de tipo retardado
AR029227A1 (es) Estructura compuesta de una matriz adhesiva que contiene una o varias substancias activas;procedimiento para fabricar una estructura compuesta, uso de estructuras compuestas y apilamiento de dichas estructuras compuestas.
BR9814756A (pt) Composição sólida seca para liberação de droga, processo para a preparação da mesma, uso de um grande número de pequenas esferas que contêm uma matriz polimérica composta de um polietileno glicol ou de uma mistura de polietileno glicóis
BR0112887A (pt) Partìculas
ES2560577B2 (es) Sensor electroquímico y procedimiento de recubrimiento, procedimiento de fabricación y usos correspondientes
AR022431A1 (es) Pelicula para uso medico, y procedimiento para producir dicha pelicula

Legal Events

Date Code Title Description
FG Grant, registration